Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehmet Altan

Showing results (71-80 of 153) with videos related to

Pageof 16
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 31, 2014
Gene signature-guided dasatinib therapy in metastatic breast cancerLajos Pusztai, Stacy Moulder, Mehmet Altan, et al.
Journal of Biosciences|September 27, 2023
Deep phenotyping of miRNAs in exercise-induced cardiac hypertrophy and fibrosisMukaddes Pala, Senay Gorucu Yilmaz, Mehmet Altan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 9, 2022
Treatment-related pulmonary adverse events induced by chemoradiation and Durvalumab affect survival in locally advanced non-small cell lung cancerTing Xu, Lirong Wu, Saumil Gandhi, et al.
American Journal of Clinical Oncology|June 9, 2021
Outcomes of Immune Checkpoint Inhibitor-related Diarrhea or Colitis in Cancer Patients With Superimposed Gastrointestinal InfectionsWeijie Ma, Zimu Gong, Hamzah Abu-Sbeih, et al.
Cancers|June 22, 2023
Physician Views on the Provision of Information on Immune Checkpoint Inhibitor Therapy to Patients with Cancer and Pre-Existing Autoimmune Disease: A Qualitative StudyMaria A Lopez-Olivo, Gabrielle F Duhon, Juan I Ruiz, et al.
JTO Clinical and Research Reports|September 12, 2022
Severe Radiation-Induced Lymphopenia Attenuates the Benefit of Durvalumab After Concurrent Chemoradiotherapy for NSCLCWang Jing, Ting Xu, Lirong Wu, et al.
Cancer|May 2, 2023
Safety, tolerability, and clinical activity of selinexor in combination with pembrolizumab in treatment of metastatic non-small cell lung cancerMehmet Altan, Janet Tu, Denái R Milton, et al.
Turkish Journal of Urology|August 11, 2022
Effect of the COVID-19 Pandemic on Radical Prostatectomy: A Turkish Multicenter StudyAbdullah Gurel, Burhan Baylan, Ibrahim Keles, et al.
Cancer Cytopathology|September 25, 2023
Detection of clinically actionable gene fusions by next-generation sequencing-based RNA sequencing of non-small cell lung cancer cytology specimens: A single-center experience with comparison to fluorescence in situ hybridizationJohn Diks, Zhenya Tang, Mehmet Altan, et al.
JMIR Cancer|October 25, 2024
Development of an Educational Website for Patients With Cancer and Preexisting Autoimmune Diseases Considering Immune Checkpoint Blockers: Usability and Acceptability StudyMaria A Lopez-Olivo, Maria E Suarez-Almazor, Gabrielle F Duhon, et al.
Pageof 16

Showing results (71-80 of 153) with videos related to

Sort By:
Pageof 16
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 31, 2014
Gene signature-guided dasatinib therapy in metastatic breast cancerLajos Pusztai, Stacy Moulder, Mehmet Altan, et al.
Journal of Biosciences|September 27, 2023
Deep phenotyping of miRNAs in exercise-induced cardiac hypertrophy and fibrosisMukaddes Pala, Senay Gorucu Yilmaz, Mehmet Altan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 9, 2022
Treatment-related pulmonary adverse events induced by chemoradiation and Durvalumab affect survival in locally advanced non-small cell lung cancerTing Xu, Lirong Wu, Saumil Gandhi, et al.
American Journal of Clinical Oncology|June 9, 2021
Outcomes of Immune Checkpoint Inhibitor-related Diarrhea or Colitis in Cancer Patients With Superimposed Gastrointestinal InfectionsWeijie Ma, Zimu Gong, Hamzah Abu-Sbeih, et al.
Cancers|June 22, 2023
Physician Views on the Provision of Information on Immune Checkpoint Inhibitor Therapy to Patients with Cancer and Pre-Existing Autoimmune Disease: A Qualitative StudyMaria A Lopez-Olivo, Gabrielle F Duhon, Juan I Ruiz, et al.
JTO Clinical and Research Reports|September 12, 2022
Severe Radiation-Induced Lymphopenia Attenuates the Benefit of Durvalumab After Concurrent Chemoradiotherapy for NSCLCWang Jing, Ting Xu, Lirong Wu, et al.
Cancer|May 2, 2023
Safety, tolerability, and clinical activity of selinexor in combination with pembrolizumab in treatment of metastatic non-small cell lung cancerMehmet Altan, Janet Tu, Denái R Milton, et al.
Turkish Journal of Urology|August 11, 2022
Effect of the COVID-19 Pandemic on Radical Prostatectomy: A Turkish Multicenter StudyAbdullah Gurel, Burhan Baylan, Ibrahim Keles, et al.
Cancer Cytopathology|September 25, 2023
Detection of clinically actionable gene fusions by next-generation sequencing-based RNA sequencing of non-small cell lung cancer cytology specimens: A single-center experience with comparison to fluorescence in situ hybridizationJohn Diks, Zhenya Tang, Mehmet Altan, et al.
JMIR Cancer|October 25, 2024
Development of an Educational Website for Patients With Cancer and Preexisting Autoimmune Diseases Considering Immune Checkpoint Blockers: Usability and Acceptability StudyMaria A Lopez-Olivo, Maria E Suarez-Almazor, Gabrielle F Duhon, et al.
Pageof 16